GEOVAX LABS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GEOVAX LABS, INC. stock issued during period, value, stock options exercised for fiscal 2017 was $571.51K, a 57.34% decline from fiscal 2016.
- GEOVAX LABS, INC. stock issued during period, value, stock options exercised for fiscal 2016 was $1.34M.
- GEOVAX LABS, INC. stock issued during period, value, stock options exercised for fiscal 2014 was $873.40K, a 46.85% decline from fiscal 2013.
- GEOVAX LABS, INC. stock issued during period, value, stock options exercised for fiscal 2013 was $1.64M.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2017-12-31 | $571.51K 10-K · filed 2019-03-26 | |
| 2016-12-31 | $1.34M 10-K · filed 2019-03-26 | |
| 2014-12-31 | $873.40K 10-K · filed 2017-03-24 | |
| 2013-12-31 | $1.64M 10-K · filed 2016-03-16 | |
| 2009-12-31 | $1.50M 10-K · filed 2014-03-14 | |
| 2007-12-31 | $5.00K 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |